Annual Retained Earnings
-$1.41 B
-$257.83 M-22.45%
31 December 2023
Summary:
Sangamo Therapeutics annual retained earnings is currently -$1.41 billion, with the most recent change of -$257.83 million (-22.45%) on 31 December 2023. During the last 3 years, it has fallen by -$628.39 million (-80.77%). SGMO annual retained earnings is now -432631.08% below its all-time high of -$325.00 thousand, reached on 31 December 1996.SGMO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.48 B
+$10.67 M+0.72%
30 September 2024
Summary:
Sangamo Therapeutics quarterly retained earnings is currently -$1.48 billion, with the most recent change of +$10.67 million (+0.72%) on 30 September 2024. Over the past year, it has dropped by -$134.84 million (-10.02%). SGMO quarterly retained earnings is now -12774.22% below its all-time high of -$11.50 million, reached on 31 March 2000.SGMO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.4% | -10.0% |
| 3 y3 years | -80.8% | -61.2% |
| 5 y5 years | -149.9% | -123.9% |
SGMO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -80.8% | at low | -61.2% | +0.7% |
| 5 y | 5 years | -149.9% | at low | -125.4% | +0.7% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +0.7% |
Sangamo Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.48 B(-0.7%) |
| June 2024 | - | -$1.49 B(+2.5%) |
| Mar 2024 | - | -$1.46 B(+3.5%) |
| Dec 2023 | -$1.41 B(+22.4%) | -$1.41 B(+4.5%) |
| Sept 2023 | - | -$1.35 B(+8.4%) |
| June 2023 | - | -$1.24 B(+10.2%) |
| Mar 2023 | - | -$1.13 B(-1.8%) |
| Dec 2022 | -$1.15 B(+20.1%) | -$1.15 B(+4.7%) |
| Sept 2022 | - | -$1.10 B(+5.1%) |
| June 2022 | - | -$1.04 B(+4.3%) |
| Mar 2022 | - | -$1.00 B(+4.6%) |
| Dec 2021 | -$956.27 M(+22.9%) | -$956.27 M(+4.1%) |
| Sept 2021 | - | -$918.77 M(+5.5%) |
| June 2021 | - | -$871.08 M(+5.7%) |
| Mar 2021 | - | -$823.91 M(+5.9%) |
| Dec 2020 | -$777.98 M(+18.4%) | -$777.98 M(+5.5%) |
| Sept 2020 | - | -$737.38 M(+0.2%) |
| June 2020 | - | -$735.83 M(+5.1%) |
| Mar 2020 | - | -$699.90 M(+6.5%) |
| Dec 2019 | -$656.99 M(+16.8%) | -$656.99 M(-0.7%) |
| Sept 2019 | - | -$661.54 M(+4.3%) |
| June 2019 | - | -$634.23 M(+5.0%) |
| Mar 2019 | - | -$603.95 M(+7.3%) |
| Dec 2018 | -$562.70 M(+13.6%) | -$562.70 M(+3.4%) |
| Sept 2018 | - | -$544.03 M(+2.4%) |
| June 2018 | - | -$531.19 M(+3.2%) |
| Mar 2018 | - | -$514.55 M(+3.8%) |
| Dec 2017 | -$495.48 M(+12.4%) | -$495.48 M(+2.7%) |
| Sept 2017 | - | -$482.39 M(+2.6%) |
| June 2017 | - | -$470.03 M(+2.7%) |
| Mar 2017 | - | -$457.54 M(+3.8%) |
| Dec 2016 | -$440.91 M(+19.4%) | -$440.91 M(+2.2%) |
| Sept 2016 | - | -$431.29 M(+4.6%) |
| June 2016 | - | -$412.32 M(+6.9%) |
| Mar 2016 | - | -$385.75 M(+4.5%) |
| Dec 2015 | -$369.25 M(+12.4%) | -$369.25 M(+3.9%) |
| Sept 2015 | - | -$355.24 M(+2.7%) |
| June 2015 | - | -$346.00 M(+3.6%) |
| Mar 2015 | - | -$333.87 M(+1.6%) |
| Dec 2014 | -$328.55 M(+8.7%) | -$328.55 M(+1.3%) |
| Sept 2014 | - | -$324.23 M(+2.4%) |
| June 2014 | - | -$316.69 M(+2.3%) |
| Mar 2014 | - | -$309.70 M(+2.5%) |
| Dec 2013 | -$302.13 M(+9.7%) | -$302.13 M(+2.8%) |
| Sept 2013 | - | -$293.99 M(+2.1%) |
| June 2013 | - | -$287.84 M(+1.9%) |
| Mar 2013 | - | -$282.39 M(+2.5%) |
| Dec 2012 | -$275.51 M(+8.8%) | -$275.51 M(+1.3%) |
| Sept 2012 | - | -$272.03 M(+2.2%) |
| June 2012 | - | -$266.24 M(+2.2%) |
| Mar 2012 | - | -$260.51 M(+2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -$253.25 M(+16.4%) | -$253.25 M(+2.6%) |
| Sept 2011 | - | -$246.89 M(+4.0%) |
| June 2011 | - | -$237.33 M(+4.5%) |
| Mar 2011 | - | -$227.07 M(+4.4%) |
| Dec 2010 | -$217.50 M(+12.9%) | -$217.50 M(+4.0%) |
| Sept 2010 | - | -$209.17 M(+4.3%) |
| June 2010 | - | -$200.48 M(+2.0%) |
| Mar 2010 | - | -$196.62 M(+2.1%) |
| Dec 2009 | -$192.64 M(+10.7%) | -$192.64 M(+1.3%) |
| Sept 2009 | - | -$190.25 M(+2.6%) |
| June 2009 | - | -$185.40 M(+2.5%) |
| Mar 2009 | - | -$180.89 M(+3.9%) |
| Dec 2008 | -$174.05 M(+16.2%) | -$174.05 M(+1.5%) |
| Sept 2008 | - | -$171.48 M(+3.8%) |
| June 2008 | - | -$165.14 M(+4.7%) |
| Mar 2008 | - | -$157.72 M(+5.3%) |
| Dec 2007 | -$149.75 M(+16.7%) | -$149.75 M(+4.7%) |
| Sept 2007 | - | -$143.08 M(+3.1%) |
| June 2007 | - | -$138.81 M(+3.9%) |
| Mar 2007 | - | -$133.63 M(+4.2%) |
| Dec 2006 | -$128.27 M(+16.2%) | -$128.27 M(+7.5%) |
| Sept 2006 | - | -$119.32 M(+2.4%) |
| June 2006 | - | -$116.48 M(+2.9%) |
| Mar 2006 | - | -$113.15 M(+2.5%) |
| Dec 2005 | -$110.41 M(+13.7%) | -$110.41 M(+2.5%) |
| Sept 2005 | - | -$107.72 M(+3.5%) |
| June 2005 | - | -$104.05 M(+3.4%) |
| Mar 2005 | - | -$100.67 M(+3.7%) |
| Dec 2004 | -$97.11 M(+16.6%) | -$97.11 M(+3.2%) |
| Sept 2004 | - | -$94.07 M(+5.1%) |
| June 2004 | - | -$89.50 M(+3.8%) |
| Mar 2004 | - | -$86.24 M(+3.5%) |
| Dec 2003 | -$83.30 M(+14.3%) | -$83.30 M(+2.1%) |
| Sept 2003 | - | -$81.62 M(+3.3%) |
| June 2003 | - | -$79.03 M(+4.3%) |
| Mar 2003 | - | -$75.76 M(+4.0%) |
| Dec 2002 | -$72.86 M(+69.1%) | -$72.86 M(+1.0%) |
| Sept 2002 | - | -$72.16 M(+40.9%) |
| June 2002 | - | -$51.22 M(+7.6%) |
| Mar 2002 | - | -$47.59 M(+10.4%) |
| Dec 2001 | -$43.10 M(+141.4%) | -$43.10 M(+8.5%) |
| Sept 2001 | - | -$39.73 M(+77.9%) |
| June 2001 | - | -$22.33 M(+12.1%) |
| Mar 2001 | - | -$19.91 M(+11.6%) |
| Dec 2000 | -$17.85 M(+102.9%) | -$17.85 M(+18.6%) |
| Sept 2000 | - | -$15.05 M(+13.7%) |
| June 2000 | - | -$13.23 M(+15.0%) |
| Mar 2000 | - | -$11.50 M |
| Dec 1999 | -$8.80 M(+75.6%) | - |
| Dec 1998 | -$5.01 M(+190.4%) | - |
| Dec 1997 | -$1.73 M(+430.8%) | - |
| Dec 1996 | -$325.00 K | - |
FAQ
- What is Sangamo Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual retained earnings year-on-year change?
- What is Sangamo Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly retained earnings year-on-year change?
What is Sangamo Therapeutics annual retained earnings?
The current annual retained earnings of SGMO is -$1.41 B
What is the all time high annual retained earnings for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual retained earnings is -$325.00 K
What is Sangamo Therapeutics annual retained earnings year-on-year change?
Over the past year, SGMO annual retained earnings has changed by -$257.83 M (-22.45%)
What is Sangamo Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SGMO is -$1.48 B
What is the all time high quarterly retained earnings for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly retained earnings is -$11.50 M
What is Sangamo Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SGMO quarterly retained earnings has changed by -$134.84 M (-10.02%)